NCT01651572View on ClinicalTrials.gov

Comparison Between Cisatracurium and Rocuronium in Terms of Recovery of the Muscular Strength in the Postoperative Phase After Surgery and General Anaesthesia

PHASE4CompletedINTERVENTIONAL

Enrollment

120

Participants

Timeline

Start Date

July 31, 2012

Primary Completion Date

July 31, 2013

Study Completion Date

July 31, 2013

Conditions

Postoperative Residual CurarizationResidual Neuromuscular Block

Interventions

DRUG

Cisatracurium

"Cisatracurium (Nimbex):~* initial dose: 0.2 mg/kg~* maintaining dose: 0.1 mg/kg (repeated anytime TOF-count reaches 2 twitches)"

DRUG

Rocuronium

"Rocuronium (Esmeron):~* initial dose: 0.6 mg/kg~* maintaining dose: 0.15 mg/kg (repeated anytime TOF-count reaches 2 twitches)"

Trial Locations (1)

35128

Azienda Ospedaliera di Padova, Padua

All Listed Sponsors

lead

Azienda Ospedaliera di Padova

OTHER

NCT01651572 - Comparison Between Cisatracurium and Rocuronium in Terms of Recovery of the Muscular Strength in the Postoperative Phase After Surgery and General Anaesthesia | Biotech Hunter | Biotech Hunter